Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction.
Alabama has the third-lowest percentage of residents fully vaccinated against COVID-19 and the second-highest COVID death rate per capita in the nation.